Titre : | The role of patient satisfaction in methadone treatment (2010) |
Auteurs : | S. M. KELLY ; K. E. O'GRADY ; B. S. BROWN ; S. G. MITCHELL ; R. P. SCHWARTZ |
Type de document : | Article : Périodique |
Dans : | American Journal of Drug and Alcohol Abuse (Vol.36, n°3, 2010) |
Article en page(s) : | 150-154 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus géographique ETATS-UNISThésaurus mots-clés METHADONE ; TRAITEMENT DE MAINTENANCE ; SATISFACTION ; OBSERVANCE DU TRAITEMENT |
Résumé : | BACKGROUND: Patient satisfaction surveys, widely used in health care delivery systems, may provide useful data for improving patient retention and outcomes. OBJECTIVES: This study examined the relationship between methadone patients' treatment satisfaction at three months post-admission and their 3-month treatment outcomes and 12-month treatment retention. METHODS: New methadone treatment admissions (N = 283) were assessed at 3 months post-admission for satisfaction with their counselors and programs. Correlations examined the relationship between 3-month satisfaction and Addiction Severity Index (ASI) scores. Regression analysis assessed the relationship between satisfaction and drug testing at 3 months and was used to predict whether participants were retained in treatment at 12 months. RESULTS: Participants who were more satisfied with their counselors and programs had lower Drug and Legal ASI composite scores at 3 months. Participants who were more satisfied with their programs remained in treatment for at least 12 months. CONCLUSIONS: Treatment programs should consider administering the CEF to their patients at 3 months post-admission to identify patients with low satisfaction scores who may be at risk for prematurely leaving treatment. SCIENTIFIC SIGNIFICANCE: Measuring patient satisfaction during treatment may help programs meet patients' needs and improve retention. [Author's abstract] |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 20 |
Affiliation : | Friends Research Institute, Inc., Baltimore, Maryland, United States / Etats-Unis. Email : skelly@friendsresearch.org |
Lien : | http://informahealthcare.com/doi/abs/10.3109/00952991003736371 |
Accueil